Thursday , June 24 2021

Enzene Biosciences Ltd. obtains marketing authorization for its first biosimilar molecule in India

Pune (Maharashtra) [India], February 4 (ANI/PRNewswire): Recently Enzene Biosciences Ltd. announced that it has obtained Marketing Authorisation (MA) from Drug Controller General of India (DCGI) for Teriparatide – bioactive part of human parathyroid hormone (PTH), an anabolic approach to the treatment of Osteoporosis, compared to the anti-resorptive therapies such as bisphosphates and SERMs.Pune (Maharashtra) [India], February 4 (ANI/PRNewswire): Recently Enzene Biosciences Ltd. announced that it has obtained Marketing Authorisation (MA) from Drug Controller General of India (DCGI) for Teriparatide – bioactive part of human parathyroid hormone (PTH), an anabolic approach to the treatment of Osteoporosis, compared to the anti-resorptive therapies such as bisphosphates and SERMs.Read More

About

Check Also

EC can hold Bengal by-polls as Covid-19 situation is under control: Mamata

West Bengal chief minister Mamata Banerjee on Wednesday said bypolls, due in six assembly seats …

Leave a Reply

Your email address will not be published. Required fields are marked *